134 related articles for article (PubMed ID: 17869521)
1. Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent.
Chakrabarty R; Rao J; Anand A; Roy AD; Roy R; Shankar G; Dua PR; Saxena AK
Bioorg Med Chem; 2007 Dec; 15(23):7361-7. PubMed ID: 17869521
[TBL] [Abstract][Full Text] [Related]
2. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
4. Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.
Campiani G; Butini S; Fattorusso C; Trotta F; Gemma S; Catalanotti B; Nacci V; Fiorini I; Cagnotto A; Mereghetti I; Mennini T; Minetti P; Di Cesare MA; Stasi MA; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2005 Mar; 48(6):1705-8. PubMed ID: 15771414
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
Gowri Chandra Sekhar KV; Rao VS; Deuther-Conrad W; Reddy AS; Brust P; Krishna Kumar MM
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):561-8. PubMed ID: 21171898
[TBL] [Abstract][Full Text] [Related]
6. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
Balle T; Perregaard J; Ramirez MT; Larsen AK; Søby KK; Liljefors T; Andersen K
J Med Chem; 2003 Jan; 46(2):265-83. PubMed ID: 12519065
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
[TBL] [Abstract][Full Text] [Related]
9. Studies towards the identification of a new generation of atypical antipsychotic agents.
Garzya V; Forbes IT; Gribble AD; Hadley MS; Lightfoot AP; Payne AH; Smith AB; Douglas SE; Cooper DG; Stansfield IG; Meeson M; Dodds EE; Jones DN; Wood M; Reavill C; Scorer CA; Worby A; Riley G; Eddershaw P; Ioannou C; Donati D; Hagan JJ; Ratti EA
Bioorg Med Chem Lett; 2007 Jan; 17(2):400-5. PubMed ID: 17084080
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.
Barceló M; Raviña E; Masaguer CF; Domínguez E; Areias FM; Brea J; Loza MI
Bioorg Med Chem Lett; 2007 Sep; 17(17):4873-7. PubMed ID: 17588750
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.
Ablordeppey SY; Lyles-Eggleston M; Bricker B; Zhang W; Zhu X; Goodman C; Roth BL
Bioorg Med Chem Lett; 2006 Jun; 16(12):3219-23. PubMed ID: 16621538
[TBL] [Abstract][Full Text] [Related]
12. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugs.
Nakazato A; Ohta K; Sekiguchi Y; Okuyama S; Chaki S; Kawashima Y; Hatayama K
J Med Chem; 1999 Mar; 42(6):1076-87. PubMed ID: 10090790
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, docking and pharmacological evaluation of novel indole based potential atypical antipsychotics.
Bali A; Sen U; Peshin T
Eur J Med Chem; 2014 Mar; 74():477-90. PubMed ID: 24495776
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent.
Ochi T; Sakamoto M; Minamida A; Suzuki K; Ueda T; Une T; Toda H; Matsumoto K; Terauchi Y
Bioorg Med Chem Lett; 2005 Feb; 15(4):1055-9. PubMed ID: 15686911
[TBL] [Abstract][Full Text] [Related]
17. Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities.
Cuisiat S; Bourdiol N; Lacharme V; Newman-Tancredi A; Colpaert F; Vacher B
J Med Chem; 2007 Feb; 50(4):865-76. PubMed ID: 17300168
[TBL] [Abstract][Full Text] [Related]
18. N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: human dopamine D4 ligands with high affinity for the 5-HT2A receptor.
Arora J; Bordeleau M; Dube L; Jarvie K; Mazzocco L; Peragine J; Tehim A; Egle I
Bioorg Med Chem Lett; 2005 Dec; 15(23):5253-6. PubMed ID: 16168646
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor ligands. Part VII [1]: novel 3-substituted 5-phenyl-1, 2, 3, 4, 5, 6-hexahydro-azepino-[4, 5-b]indoles as ligands for the dopamine receptors.
Decker M; Lehmann J
Arch Pharm (Weinheim); 2003 Oct; 336(10):466-76. PubMed ID: 14582123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
